An observational study in Apnea of Prematurity, sponsored by Wyss Institute at Harvard University. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2015-09-10.
Sponsored by Wyss Institute at Harvard University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 85 studies in Apnea with a site in United States — 15 open to participants now, 18 under way, 2 of them phase 3. Apnea · United States.
Among the 85 studies in Apnea with a site in United States, this one is the 15th largest by enrollment of the 16 observational ones that give a count, is one of 8 that started in 2012, is one of 16 observational ones, and was the 25th registered.
283 studies on the registry are indexed under Apnea; 55 are open to participants now.
Browse Apnea studies →15 of the 85 studies in Apnea with a site in United States are open now. Recruiting first, the newest first:
Pfizer · Sites in United States
Ages 18+
University of Alabama at Birmingham · Sites in United States
Ages 22 wk–32 wk
Pfizer · Sites in United States
Ages 18+
University of Rochester · Sites in United States
Ages 0 days–27 wk
University of North Carolina, Chapel Hill · Sites in United States
Ages 8–13 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 40 Apnea studies recruiting now, 9 (23%) set no upper age limit and 27 (68%) stop at 75 or younger; 19 take children under 18; 16 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
85 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 3 · Phase 3 6 · Phase 4 8
First in 1999; this study’s year is marked. 8 started in 2012.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 36 is below the median of 60 across 78 observational studies indexed under Apnea.
Median enrollment 80 across the 69 interventional studies, 113 across the 16 observational. Of the 58 that completed or were terminated, 23 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 85 have an industry lead sponsor. The 10 most frequent:
Wyss Institute at Harvard University is the lead sponsor of 5 studies on the registry; none are open to participants now.
Wyss Institute at Harvard University has 1 study filed under Apnea — fewer than ten, so there is no comparison to draw.
8 of the studies in Apnea with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06327152University of California, IrvineCaffeine Use in the Management of Preterm Infants | 2026-12 |
| NCT02431507Michael HarrisonMagnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety | 2026-12-01 |
| NCT07581938University of North Carolina, Chapel HillEarly Dental Risk Screening for Pediatric Sleep-Disordered Breathing | 2027-05 |
| NCT05527652University of MichiganSelf-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia | 2027-05 |
| NCT07570121Indiana UniversityPharmacokinetics and Placental Transfer of Caffeine | 2027-06 |
Add all 8 to your calendar (.ics) → With an account.
Among the 85 studies in Apnea with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to explore physiological interventions and biomarkers for Apnea of Prematurity in newborn infants.
Apnea of prematurity is defined as cessation of breathing that lasts for more than 20 seconds and/or is accompanied by oxygen desaturation or a decrease in heart rate (bradycardia). Because apnea presents itself within a variety of diseases in newborns, its diagnosis is based largely on the exclusion of other findings. The difficulty in relating the manifestation of apnea to its cause can lead to issues regarding appropriate medical management and delays in treatment.
Our exploration of physiological interventions for Apnea of Prematurity begins with stochastic resonance. Stochastic resonance is the introduction of noise to a system, to alter the system's behavior. This technology has been examined in previous medical applications. The hypothesis for this work is that stochastic resonance stimulation, in the form of gentle vibrations, will stabilize immature breathing patterns in infants.
In this research study, we will use an apnea mattress developed by engineers at the Wyss Institute, Harvard University, which provides gentle vibrations to the infant. We will closely follow the research protocol from UMass Medical School. Whilst the infant is on the mattress, clinical care data will be collected to determine effect on breathing patterns. We also hope to collect enough baseline and intervention data signals to be able to identify candidate biomarkers for apnea. This will assist in development of predictive algorithms for apnea in infants.
Infants currently inpatient in the Neonatal Intensive Care Unit at Beth Israel Deaconess Medical Center.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligible subjects are infants currently inpatient in the NICU at Beth Israel Deaconess Medical Center and:
Exclusion Criteria:
Eligible infants meeting the inclusion criteria above will be excluded from participation in the study if he/she:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The infant's isolette mattress will be replaced with a specially designed mattress (non-commercially available, designed by engineers at the Wyss Institute, Harvard University) to provide gentle vibrations and sounds during mattress stimulations.
Device: Stochastic Resonance Mattress
The infant's isolette mattress will be replaced with a specially designed mattress (non-commercially available, designed by engineers at the Wyss Institute, Harvard University) to provide gentle vibrations and sounds during mattress stimulations.
Investigate effects of mattress intervention on breathing patterns
Focus on inter-breath intervals and oxygen desaturation.
Time frame: Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.
Candidate Biomarkers for Apnea of Prematurity
Candidate biomarkers in cardio-pulmonary, temperature, audiometry, photometry and clinical assessment data.
Time frame: Each study session may last up to 24 hours. Participants may take part in up to 4 study sessions.
The record gives a start of Jul 2012, a primary completion of Jul 2014 and a completion of Jul 2014. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wyss Institute at Harvard University